PDUFA dates April 2018: FDA calendar and catalysts.
0 PDUFA dates fell in April 2018. The FDA calendar also recorded 1 other catalyst that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.
PDUFA dates in April 2018
No PDUFA dates are disclosed for this period as of November 16, 2026.
Download: CSV · JSON · iCal (next 30 days, CC BY 4.0) · Calendar API · All months
April 2018: other FDA decisions and filings
| Date | Drug | Company | Event | Indication | Status | Source |
|---|---|---|---|---|---|---|
| April 20, 2018 | Trazimera (trastuzumab-qyyp) | PFE | Complete Response Letter | — | CRL issued | FDA Complete Response Letters |
April 2018: dated readouts
No events in this view.
Not submitted to search engines: Fewer than 3 sourced events in the month.
Questions
What PDUFA dates are in April 2018?
0 PDUFA dates fell in April 2018. The FDA calendar also recorded 1 other catalyst that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.
Can these dates change?
Yes. The FDA can extend a review by three months after a major amendment, and it sometimes acts before the goal date. Each row links the filing the date came from.
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.